Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
1(7%)
Results Posted
73%(8 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_4
5
36%
Ph phase_3
4
29%
Ph phase_1
1
7%
Ph phase_2
1
7%

Phase Distribution

1

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
4(36.4%)
Phase 4Post-market surveillance
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(11)
Terminated(1)

Detailed Status

Completed11
Not yet recruiting1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 21 (9.1%)
Phase 34 (36.4%)
Phase 45 (45.5%)

Trials by Status

completed1179%
not_yet_recruiting17%
terminated17%
recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
recruitingphase_2

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

NCT05417776
completedphase_3

Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

NCT06057168
not_yet_recruitingphase_1

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

NCT06600880
completed

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

NCT03023566
completed

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

NCT05199792
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT05417776Phase 2

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Recruiting
NCT06057168Phase 3

Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

Completed
NCT06600880Phase 1

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Not Yet Recruiting
NCT03023566

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

Completed
NCT05199792

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

Completed
NCT03910114

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography

Completed
NCT02411201Phase 4

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Completed
NCT02070380Phase 4

Crossover Comparison of MultiHance and Dotarem

Completed
NCT02034708Phase 4

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

Completed
NCT01010932Phase 3

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Completed
NCT01012674Phase 3

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Completed
NCT00980681Phase 3

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Terminated
NCT00764387Phase 4

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Completed
NCT01026389Phase 4

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14